Ishiclo-P Tablet contains a combination of Aceclofenac 100 mg and Paracetamol 325 mg, formulated to provide effective relief from pain and inflammation. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol, an analgesic and antipyretic agent, enhances pain relief and helps reduce fever by acting centrally on the hypothalamic heat-regulating center. This combination is commonly prescribed for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other conditions characterized by mild to moderate pain and inflammation. Ishiclo-P Tablet offers the advantage of improved efficacy through the synergistic action of its components, providing rapid onset of pain relief with a favorable safety profile when used as directed. It is contraindicated in patients with known hypersensitivity to Aceclofenac, Paracetamol, or other NSAIDs, and should be used cautiously in individuals with hepatic, renal, or cardiovascular impairment. Patients are advised to follow the prescribed dosage and consult a healthcare professional before use, particularly if pregnant, breastfeeding, or taking other medications to avoid potential drug interactions and adverse effects.